The American Medical Association and more than two dozen other health organizations joined in an amicus brief encouraging the ...

The FDA has extended its review of the ProSense cryoablation system for early-stage breast cancer, with a decision expected ...

IceCure Medical Ltd. ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor ...

Fusion biopsy and patient follow-up with 3D mapping are the cornerstone of a successful Focal Therapy program. In line with ...

Cryoablation, the destruction of malignant cancer cells by freezing them, is increasingly becoming an alternative to having ...

IceCure Medical Ltd’s ICCM share price has dipped by 12.84%, which has investors questioning if this is right time to buy.

PR Newswire CAESAREA, Israel IceCure working in close collaboration with FDA towards De Novo decision CAESAREA, Israel /PRNewswire/ -- IceCure Medi ...

AI-driven tumor mapping with Unfold AI helps doctors more accurately assess prostate cancer size, improving treatment success ...

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who is most ...

A new UCLA study has found that artificial intelligence could help doctors identify prostate cancer patients most ...

A new artificial intelligence tool could help doctors determine which prostate cancer patients are most likely to benefit ...

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment ...